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Background: In histopathology, quantitative assessment of  various morphologic 
features is based on published methods that were conceived on specific areas 
observed through the microscope and microscopical objective used. Failure to 
reproduce the same reference field size if using a different microscope may change 
the score assessed. When visualizing a digital slide on a computer screen, through a 
dedicated viewer, it is possible to select the adequate objective-magnification (zoom 
toolbar). However, the field of view is rectangular, different from the circular field 
area viewed by optical microscopy. In addition, the evaluation of the size of the 
selected area of the digital slide is not immediately evident and must be estimated 
with the draw functions of the viewer or the scale/axes grid.  
Methods: Using the tools offered by ImageScope, the virtual slide viewer of Aperio 
Technologies (Vista, USA), a system was conceived to reproduce the various 
methods published for assessing tumor budding, an important prognostic factor in 
colorectal cancer. Each method, based on counting tumor budding within a specific 
area, was reproduced as a colored circle, corresponding to a graphic overlay layer.  
The various circles were grouped in a target-like shape and then exported and saved 
as an .xml file. A web page was created giving access to 100 whole-slide digital 
scans. When each digital slide was opened the file containing the target-like area had 
to be imported in order to move it onto a tumor budding “hot spot” and to perform the 
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measurements. Eighteen international experts in gastrointestinal pathology were 
invited to participate.  
Results: Twelve investigators completed the task, the majority of them performing 
the multiple assessments of each case in less than 12 minutes. 
Conclusions: The assessing system proposed appeared to be feasible for pathologists. 
It allows precise application of methods originally conceived for optical microscopy.  
The graphical layers that make the tool are freely moved within the digital slide: this 
system was named DSDM (Digital Slide Dynamic Morphometry). This telepathology 
extension has various potential applications and might be a useful tool for 
histopathological assessment of diagnostic parameters that need to be quantified.  
 
INTRODUCTION 
Most applications of telepathology have previously been limited to remote  frozen 
intra-operative diagnosis1,2 or second opinion consultations.3 More recently, 
additional applications have included evaluation of interobserver variability of 
histopathologic diagnosis,  using offline telepathology,4-6 and computer-assisted 
image analysis for morphometric quantification of prognostic factors.7,8 In routine 
histopathology, quantitative assessment of  various morphologic features is based on 
published methods that were based on fields of view specifically obtained with the 
microscope used by the original descriptors (authors) and expressed as an area (in 
mm2) or a magnification (high power field: HPF).  
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This assessing system applies  both to inflammatory and neoplastic diseases. 
In addition to different microscopes and objectives (magnification) used (thus 
different field of view areas) the various authors used different cut-offs and different 
approaches for assessing a specific feature, such as subjective evaluation vs. objective 
quantification. The assessment is performed throughout the whole lesion (multiple 
slides) or on the most representative slide, containing the “hot spot”, and/or in 
multiple additional areas randomly searched. The cut-off values can be arbitrary 
chosen or based on outcome analysis or on inter/intraobserver analysis. 
An example of variation in field areas is given by the results published by different 
investigators studying inflammatory diseases, e.g the reported mean - SD 
concentration of mucosal mast cells in the control population of colonic biopsies is 
13.3 +/- 3.59 and 37.3 +/- 6.0 per HPF.10 
An example of variation in cut-off values is represented by the number of 
eosinophils/HPF (based on peak count) used to establish a diagnosis of oeosinophilic 
oesophagitis which has been reported as being 15 in 10 studies, 20 in 8 studies, 24 in 
2 studies and 30 in 1 study.11 
 In neoplastic disease, the mitotic count is an important prognostic factor and is also 
an essential component of  histological grade in breast cancer. 
This enumeration is greatly influenced by the variation in HPF when using different 
microscopes, (the variation being up to 250%) and by the method used for counting 
mitotic figures and recording results.12 
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In order to routinely apply a given method, one should try to adapt the field size and 
the cut-off values indicated, with a correction formula considering the particular field 
of view and the objective magnification of his own microscope. Failure to reproduce 
the same reference field size will likely change the score assessed. 
Although the CAP Invasive Breast Cancer Protocol provides a table to adjust the raw 
number of mitoses according to the size of the field (either by diameter or area in 
mm2) of the microcope used,13 mitotic count cutoffs are subject to important 
sampling errors and prognostic or predictive cutoffs are not well studied.14 
The need for standardizing mitotic count in Gastrointestinal Stromal Tumors, 
according to the surface area examined (based on size of HPFs) has already been 
underlined: once more the problem is that there are no agreed-upon definitions in this 
regard.15 
Tumor budding (TB) is a dedifferentiation process occurring at the invading edge of 
colorectal cancer (CRC) and of several epithelial malignancies. 
It appears as clusters of undifferentiated cells detaching from the surrounding tumor 
(Figure 1). 
Although several studies have shown that TB is independently associated with lymph 
node and distant metastasis, shorter disease-free survival and overall survival, in 
stages I to III CRC, there is no consensus in assessing this feature, therefore its 
clinical impact is still limited.16 
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Several original methods have been proposed for assessing TB in CRC. They can 
grouped as follows: 
1. methods based on a subjective impression on the overall tumor: Hase17 and 
Nakamura (Figure 2).18,19 
2. methods based on counting with a cut-off in the field with maximum TB 
advanced by Ueno for early20 and advanced CRC.21 
3. methods developed with counting in different areas: Morodomi22 and Wang 
(Figure 3).23 
While some authors report that budding clusters are easily identifiable on 
hematoxylin & eosin stained sections,21,23 others use immunohistochemistry to better 
assess this feature (Figure 4).24 
Such differences in methodology makes it impossible to compare data from different 
studies. 
 
MATERIALS AND METHODS 
Technical background 
When using digital slide viewers it is possible to select the observation magnification 
(zoom toolbar), because the original high resolution virtual slide is recorded in a 
pyramidal format, thanks to precomputed subsampled images. However, the field of 
view delivered by the viewer on the computer screen is rectangular and, as a result, 
different from the circular field area viewed through an optical microscope. In 
 7
addition, the evaluation of the size of the selected area of the digital slide is not 
immediately evident and must be evaluated using the draw functions of the viewer or 
the scale/axes grid.  
However telepathology seems to be the only way to efficently and swiftly reproduce 
the various proposed methods, to compare them and to evaluate inter-observer 
reproducibility. 
This  paper details  a new strategy, Digital Slide Dynamic Morphometry, that allows 
to precisely reproduce one or multiple assessing methods. This system was tested in 
the frame of an interobserver study, assessing the reproducibility of a number of 
tumour budding scoring methods, applied to fifty CRC cases. 
 
Approach 
Using telepathology on virtual slides a system was conceived to reproduce the 
various methods published for assessing TB in CRC.  
High-resolution, whole-slide images were recorded from histological slides of 50 
CRCs stage I-III of the “G.Fracastoro” City Hospital., using a ScanScope CS 
microscopical scanner (Aperio Technologies, Vista, CA). 
A web page (Figure 5) was built giving access to all the virtual slides (50 
hematoxylin & eosin stained histological sections and 50 corresponding AE1-3 
cytokeratin immunostained  sections, scanned at a magnification of 40x). 
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The digitized slides were uploaded to the study website 
http://course.path.mgh.harvard.edu/budding_project/, as tiled TIFF 6 files, 
compressed in JPEG 2000 at medium quality (70), for online viewing through a 
digital microscope interface (Aperio ImageScope) that allowed navigation from the 
desktop computers of the participating pathologists. 
It was possible to apply methods based on subjective evaluation on the whole tumor 
section, just by navigating into the virtual slide. 
An original assessing system was conceived for reproducing the methods based on 
tumour bud enumeration using cut-off values in the field of maximum budding and 
for also reproducing the methods proposed for counting budding in different tumor 
areas. 
Each method, based on counting TB within a specific area, was reproduced as a 
colored circle, drawn using the draw annotations function of the Aperio ImageScope 
viewer and corresponding to a graphic overlay layer with all the pertinent 
information: size, cut-off value, author and year of publication (Figure 6).  The 
various circles were grouped in a target-like shape (Figure 6) and then exported and 
saved as a .xml file (Figure 7). 
When each digital slide was opened the file containing the target-like area was 
imported in order to perform the assessment (Figures 8-10). 
Once the target-like area appeared, it was possible  with the Zoom Toolbar  of 
ImageSope to magnify or shrink the current field of view until the “target” was fitting 
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the monitor (Figure 11). The magnification was not important in order to reproduce 
one method, as the area was fixed. 
To move the target around the slide the keyboard keys were used. 
It was possible to move all the circles together, holding Shift-Control keys or, after 
having selected one layer, to move a circle separately from the others holding the 
Shift key. 
So the various layers were not merged together nor burned into the image, allowing a 
fully dynamic assessment. 
To indicate and report the position of the tumor region with maximum TB (the “hot 
spot”) looking at the Status Bar that provides information regarding the coordinates 
of each pixel indicated by the pointer, as the mouse is moved over the virtual slide 
(the first is ‘X’ and the second is ‘Y’),  after having indicated with the pointer the 
centre of the target, the coordinates were written down. 
A tutorial video was prepared with a screen video capture software (TechSmith 
Camtasia Studio 6, Okemos, MI, USA) while recording also the audio from a 
microphone, in order to explain how to perform the assessment. The video was 
uploaded into the study website as a Windows Media file (.wmv). 
An Excel file (Figure 12) to be filled was also provided, containing all the 100 slides 




Eighteen pathologists and surgeons trained in pathology, experts in gastrointestinal 
pathology and/or working in a cancer center, were invited to participate. 
During the initial contact, the invitees were given basic background information on 
the aims, methods, and objectives of the study. 
The set was reviewed according to the availabilities of each participant between 
December and February 2009.  
The pathologists who agreed to participate received a folder containing:  
1. the Excel file to be filled during the TB assessment;  
2. the Web Page Address file;  
3. a word file containing the detailed description of the project and the various 
methods for assessing and reporting TB;  
4. a .xml file containing three colored circles, each of them representing a 
method, (the “target”) to be imported and displayed onto each slide;  
5. A questionnaire with requests  concerning the type of hospital, the specialty, 
the time expense for filling the Excel table categorized as <10 hours / 10-15 
hours / 20-25 hours / >25 hours. 
Each participant was asked to evaluate all the 100 slides and to report TB assessment 
by highlighting Excel cells corresponding to the various TB classifications (such as 
positive vs. negative; low grade vs. high. grade etc.). 
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Completed excel files were faxed or e-mailed to the data collector who forwarded 
them to the study biostatistician for analysis.  
 
RESULTS 
Of the 18 invited investigators, 12 completed the task. 
Four investigators preferred to perform the assessment as groups of two, therefore the 
total number of submitted files was ten. 
The reasons for the failure of the remaining 6 investigators to participate included: 
technical problems viewing the tutorial video (one); a technical problem opening the 
digital slides (one); and a missed deadline (four).  
Two assessment were performed by Japanese surgeons with a vast experience of 
CRC histopathology, being also authors of the methods for assessing TB; the other 
participants were pathologists. 
The assesment  took less than 10 hours for both  hematoxylin & eosin stained slides 
and corresponding cytokeratin immunostains in 6 of 10 performances; for two 
investigators the assessment of hematoxylin & eosin stained slides lasted longer (15-
20 vs. 10-15 and <10); for one investigator it was the opposite (15-20 hours vs. 20-
25). The remaining assessment was performed for both stainings in more than 25 
hours. 
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Therefore the majority of the assessments took less than 10 hours for each 50 case 
set, (i.e. less than 12 minutes per case, keeping in mind that for each case, 5 different 
assessment methods were tested). 
 
CONCLUSIONS 
The assessing system proposed appeared to be feasible and time economical for 
pathologists considering the  multiple different methods assessed. 
Viewing the tutorial video was essential to understanding how to perform the 
morphometric analysis. 
The assessing system allows simultaneous application of different methods originally 
conceived for optical microscopy, by using customized tools prepared to precisely 
reproduce those methods.  The graphic overlay layers that make the tool can be freely 
moved within the digital slide and one can keep them separate or grouped. For this 
reason, the system was named DSDM (Digital Slide Dynamic Morphometry). This 
telepathology extension has various potential applications and might be a useful 
diagnostic tool for histopathological assessment of parameters that need to be 
quantified. This approach might be also a tool for quality control of grading 






Figure 1. The tumor budding (TB) appears as clusters and single undifferentiated 
cells detaching from the surrounding tumor. Hematoxylin & eosin. 
 
 
Figure 2. The Nakamura method for assessing TB, based on the subjective 




Figure 3. The Wang method developed with counting in different areas. Extracted 






Figure 4. The advancing edge of a CRC showing TB, stained with hematoxylin & 
















Figure 6 The advancing edge of a CRC showing TB, stained with 
immunohistochemistry (AE1-3). From the ImageScope viewing window, the 
following elements are selected: Zoom Toolbar indicating the magnification; 
Thumbnail Window showing what part of the entire image is under evaluation; Status 
Bar showing the target coordinates (‘X’ and ‘Y’). The annotation panel showing the 
multiple (three) annotation layers, saved in different colours, and organized with 
descriptions (Author, year of publication; size area, and cut-off values used by such 
author; the same cut-off value is also reminded, highlighted with the corresponding 








Figure 7. The TB kit that each participating pathologist received as folder containing 
from the left to the right: the Excel file to be filled during the TB assessment; the 
Web Page Address file; the word file containing the detailed description of the 
project and the various methods for assessing and reporting TB; the .xml file 










Figure 8. The annotation panel is selected. 
 
 
Figure 9. Within the annotation panel the import annotation from file is selected and 








Figure 11. With the zoom toolbar it is possible to adjust the magnification, until 





Figure 12. The Excel file to be filled by highlighting the cells, containing all the 100 






Additional data files. 
The video file (.wmv) shows how to navigate into a digital slide, how to import the 
annotations that is the “target” and the movement of the circles that make the target 
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